Nashed N, Chandra P
Cancer Lett. 1980 Aug;10(2):95-107. doi: 10.1016/0304-3835(80)90032-4.
A new short-term mammalian carcinogenicity test system is presented in which an in vivo application in rats is followed after 2 weeks by an in vitro culture of the peritoneal cells. One week of culture was sufficient to induce colony growth in soft agar in some cultures of the dimethylnitrosamine (DMNA)-treated, but not in those of control, rats. The results proved to be reproducible and dose-related. Suspended colony growth was not observed in cultures of control rats stimulated successively by the 2 mitogens: thioglycollate and Al(OH)3. The incidence of rats showing transformed colonies in their cultures after a single DMNA dose of 20 mg/kg was nearly double that reported for rats developing tumors after a higher single dose of 30 mg/kg DMNA. More recent experiments have shown that whereas the carcinogen benzo[a]pyrene was positive, its non-carcinogenic analog benzo[e]pyrene was negative; both applied at a single oral dose of 15 mg/kg. A similar result was observed with the acetylaminofluorene (AAF) analogs: 2-AAF and 4-AAF, where the former, a carcinogen, proved positive and the latter, a non-carcinogen, negative. Both analogs were applied at a single oral dose of 50 mg/kg. 2-AAF was also positive at a dose of 25 mg/kg corresponding to 2.5% of the highest tolerable dose of this carcinogen. These results suggest a high structure-related specificity of our test system. Many more similar tests with carcinogen/non-carcinogen analogs will be needed however, before this specificity can be sufficiently established.
本文介绍了一种新的短期哺乳动物致癌性测试系统,该系统先在大鼠体内进行应用,两周后对腹膜细胞进行体外培养。对于经二甲基亚硝胺(DMNA)处理的大鼠的某些培养物,一周的培养足以诱导软琼脂中的集落生长,但对照大鼠的培养物则不然。结果证明具有可重复性且与剂量相关。在先后用两种有丝分裂原:巯基乙酸盐和氢氧化铝刺激的对照大鼠培养物中未观察到悬浮集落生长。单次给予20mg/kg DMNA后,其培养物中出现转化集落的大鼠发生率几乎是单次给予更高剂量30mg/kg DMNA后发生肿瘤的大鼠报告发生率的两倍。最近的实验表明,致癌物苯并[a]芘呈阳性,而其非致癌类似物苯并[e]芘呈阴性;两者均以15mg/kg的单次口服剂量给药。在乙酰氨基芴(AAF)类似物:2-AAF和4-AAF中观察到了类似结果,其中前者作为致癌物被证明为阳性,后者作为非致癌物为阴性。两种类似物均以50mg/kg的单次口服剂量给药。2-AAF在25mg/kg的剂量下也呈阳性,该剂量相当于这种致癌物最高耐受剂量的2.5%。这些结果表明我们的测试系统具有高度的结构相关特异性。然而,在能够充分确定这种特异性之前,还需要用更多的致癌物/非致癌物类似物进行更多类似测试。